BIOREPOSITORY CENTER

生物样本库中心

• 批准号: 8436441
• 负责人: William L. Carroll
• 金额: $ 13.74万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-03-01 至 2018-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8436441
• 关键词: Anatomy; Biological Models; Cancer Center Support Grant; Clinical; Collaborations; Diagnosis; Disease Progression; Doctor of Philosophy; Ensure; Genetic; Goals; Guidelines; Health Insurance Portability and Accountability Act; Human; Informed Consent; Institutes; Institutional Review Boards; Instruction; Investigation; Link; Malignant Neoplasms; Non-Malignant; Operative Surgical Procedures; Pathologic Processes; Pathologist; Pathology; Patient Care; Patient Rights; Play; Preparation; Privacy; Protocols documentation; Research; Research Personnel; Role; Scientist; Services; Surgeon; Tissue Banks; Tissue Sample; Tissues; Translational Research; Work; biobank; design; human disease; human tissue; member; novel therapeutics; prospective; repository; sample collection

PROJECT SUMMARY (See instructions): The overarching goal of the BioRepository Center (BRC) is to facilitate translational research. Tight coordination between surgical staff, pathologists, and BRC enables collection of specimens to fulfill investigators' needs. Our protocols for rapid acquisition of tissue samples allows for preparation of high quality analytes. Patients' rights and privacy by our participation in obtaining and confirming informed consent for tissue collection; guidance with regard to preparation and submission of IRB documents is offered to help ensure compliance. The BRC also promotes collaborations between clinical and basic scientists, and can aid in the design and execution of prospective, hypothesis-driven studies to examine the impact of genetics or treatment on disease progression. By promoting investigators access to appropriate biospecimens, the BRC enhances the ability of NYULMC Cancer Institute members to perform meaningful translational research.

项目摘要（请参阅说明）： 生物验证中心（BRC）的总体目标是促进转化研究。手术人员，病理学家和BRC之间的紧密协调使标本收集以满足研究人员的需求。我们快速获取组织样品的方案可以制定高质量的分析物。通过我们参与获得和确认组织收集的知情同意，患者的权利和隐私；提供有关IRB文件的准备和提交的指导，以帮助确保合规。 BRC还促进了临床和基础科学家之间的合作，并可以帮助设计和执行前瞻性，假设驱动的研究，以检查遗传学或治疗对疾病进展的影响。通过促进研究人员获得适当的生物测量，BRC增强了NYULMC癌症研究所成员进行有意义的转化研究的能力。